课题基金 / 基金详情

A triple-blind, placebo-controlled, randomized clinical trial of CANnabinoids for Drug Resistant Epilepsy (CAN-DRE) in adults and children

A triple-blind, placebo-controlled, randomized clinical trial of CANnabinoids for Drug Resistant Epilepsy (CAN-DRE) in adults and children
大麻素治疗成人和儿童耐药性癫痫 (CAN-DRE) 的三盲、安慰剂对照、随机临床试验
批准号:
479757
负责人:
Kelly Lauren
金额:
$54.62万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-03-01 至 2026-03-01

项目摘要

项目成果

Kelly Lauren的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Close to 300,000 people in Canada have epilepsy, and more than 30% of people with epilepsy do not respond well to conventional therapies. Drug-resistant epilepsy (DRE) is when people do not respond to several seizure medications and is challenging for cli
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Increasing capacity for Maternal and PAediatric Clinical Trials (IMPACT) in Canada
  • 批准号:
    466180
  • 项目类别:
    Operating Grants
  • 资助金额:
    $357.5万
  • 财政年份:
    2022
  • 负责人:
    Kelly Lauren
  • 依托单位:
Increasing capacity for Maternal and PAediatric Clinical Trials (IMPACT) in Canada
  • 批准号:
    481156
  • 项目类别:
    Operating Grants
  • 资助金额:
    $89.38万
  • 财政年份:
    2022
  • 负责人:
    Kelly Lauren
  • 依托单位:
Cannabis for symptom management in children with cancer: a demonstration project by the Canadian Childhood Cannabinoid Clinical Trials (C4T) platform
  • 批准号:
    418129
  • 项目类别:
    Operating Grants
  • 资助金额:
    $72.78万
  • 财政年份:
    2019
  • 负责人:
    Kelly Lauren
  • 依托单位:
海外基金